| Literature DB >> 29482643 |
Gabriel Moore1,2, Sally Redman3,4, Sian Rudge3, Abby Haynes3,4.
Abstract
BACKGROUND: Rapid reviews are increasingly used by policy agencies to access relevant research in short timeframes. Despite the growing number of programmes, little is known about how rapid reviews are used by health policy agencies. This study examined whether and how rapid reviews commissioned using a knowledge brokering programme were used by Australian policy-makers.Entities:
Keywords: Health policy; Knowledge translation; Policy-makers; Rapid review; Rapid synthesis; Research utilisation
Mesh:
Year: 2018 PMID: 29482643 PMCID: PMC5828139 DOI: 10.1186/s12961-018-0293-1
Source DB: PubMed Journal: Health Res Policy Syst ISSN: 1478-4505
Fig. 1Data input and analysis
Fig. 2Number of eligible reviews
Use of reviews by type of agency
| Frontline government agencies | Central government agencies | Government funded agencies | Non-government organisations | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Did you use the review? |
| % |
| % |
| % |
| % |
| % |
| Yes | 80 | 95.2 | 25 | 100 | 25 | 96.2 | 4 | 100 | 134 | 89.3 |
| No | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No, but use is planned | 3 | 3.6 | 0 | 0 | 1 | 3.8 | 0 | 0 | 4 | 2.7 |
| Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Not stated | 1 | 1.2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.7 |
| Not interviewed | n/a | 0 | n/a | n/a | n/a | n/a | n/a | n/a | 11 | 7.3 |
| Total | 84 | 100 | 25 | 100 | 26 | 100 | 4 | 100 | 150 | 100 |
| Was it used in one or more policy processes? | ||||||||||
| Used in a single policy process | 15 | 17.9 | 3 | 12 | 4 | 15.4 | 1 | 25 | 23 | 15.3 |
| Used in multiple policy processes | 68 | 81 | 22 | 88 | 22 | 84.6 | 3 | 75 | 115 | 76.7 |
| Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Not stated | 1 | 1.2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.7 |
| Not interviewed | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11 | 7.3 |
| Total | 84 | 100 | 25 | 100 | 26 | 100 | 4 | 100 | 150 | 100 |
| In what policy process was it used? | ||||||||||
| In policy agenda-setting | 31 | 36.9 | 23 | 92.0 | 6 | 23.1 | 1 | 25.0 | 61 | 40.7 |
| In research agenda-setting | 1 | 1.2 | 0 | 0.0 | 2 | 7.7 | 2 | 50.0 | 5 | 3.3 |
| In policy or programme development | 43 | 51.2 | 2 | 8.0 | 16 | 61.5 | 1 | 25.0 | 62 | 41.3 |
| In policy or programme implementation | 2 | 2.4 | 0 | 0.0 | 1 | 3.8 | 0 | 0.0 | 3 | 2.0 |
| In policy or programme evaluation | 2 | 2.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 1.3 |
| In a research process | 4 | 4.8 | 0 | 0.0 | 1 | 3.8 | 0 | 0.0 | 5 | 3.4 |
| Other | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| Not stated | 1 | 1.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.7 |
| Not interviewed | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11 | 7.3 |
| Total (all instances) | 84 | 100.0 | 25 | 100.0 | 26 | 100.0 | 4 | 100.0 | 150 | 100.1 |
| How was it used? | ||||||||||
| Instrumental use | ||||||||||
| To determine the details of a policy or programme | 52 | 26.7 | 3 | 4.8 | 19 | 26.4 | 2 | 20 | 76 | 22.5 |
| To identify or evaluate alternative solutions for a policy or programme | 12 | 6.2 | 17 | 27.4 | 5 | 6.9 | 1 | 10 | 35 | 10.4 |
| To communicate information to stakeholders or the general public | 14 | 7.2 | 0 | 0 | 12 | 16.7 | 1 | 10 | 27 | 8 |
| To develop a clinical guideline, protocol or resource | 9 | 4.6 | 1 | 1.6 | 7 | 9.7 | 0 | 0 | 17 | 5 |
| To determine the details of a research programme or process | 12 | 6.2 | 0 | 0 | 2 | 2.8 | 1 | 10 | 15 | 4.4 |
| To design or inform data collection, data linkage or data analysis | 3 | 1.5 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0.9 |
| To determine the details of an evaluation programme or framework | 1 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.3 |
| Subtotal 1: Instrumental use |
|
|
|
|
|
| ||||
| Conceptual use | ||||||||||
| To determine priorities for future action or investment | 36 | 18.5 | 18 | 29 | 11 | 15.3 | 1 | 11.1 | 66 | 19.5 |
| To prepare for or negotiate a decision across agencies or jurisdictions | 25 | 12.8 | 19 | 30.6 | 2 | 2.8 | 1 | 10 | 47 | 13.9 |
| To understand the nature or extent of a problem | 13 | 6.7 | 3 | 4.8 | 4 | 5.6 | 2 | 20 | 22 | 6.5 |
| To confirm thinking or verify ideas | 5 | 2.6 | 1 | 1.6 | 7 | 9.7 | 0 | 0 | 13 | 3.8 |
| To create impetus for change | 1 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.3 |
| Subtotal 2: Conceptual use |
|
|
|
|
|
| ||||
| Symbolic use | ||||||||||
| To consult with stakeholders or to seek consensus | 8 | 4.1 | 0 | 0 | 2 | 2.8 | 0 | 0 | 10 | 3 |
| To justify or strengthen an existing policy position | 4 | 2.1 | 0 | 0 | 1 | 1.4 | 0 | 0 | 5 | 1.5 |
| Subtotal 3: Symbolic use |
|
|
|
|
|
| ||||
| Subtotal 1: Instrumental use | 103 | 52.8 | 21 | 33.9 | 45 | 62.5 | 5 | 55.6 | 174 | 51.5 |
| Subtotal 2: Conceptual use | 80 | 41 | 41 | 66.1 | 24 | 33.3 | 4 | 44.4 | 149 | 44.1 |
| Subtotal 3: Symbolic use | 12 | 6.2 | 0 | 0 | 3 | 4.2 | 0 | 0 | 15 | 4.4 |
| Total (all instances) | 195 | 100 | 62 | 100 | 72 | 100 | 9 | 100 | 338a | 100.0 |
| What evidence of use was provided? | ||||||||||
| Details specified during interviews | ||||||||||
| The ministries, agencies or people who commissioned the review | 84 | 37.5 | 25 | 39.7 | 26 | 34.2 | 4 | 57.1 | 139 | 100.0 |
| The policy, programme or guideline to which the findings contributed | 73 | 32.6 | 23 | 36.5 | 22 | 28.9 | 2 | 28.6 | 120 | 86.3 |
| The target audience(s) (if additional to those commissioning the review) | 39 | 17.4 | 11 | 17.5 | 13 | 17.1 | 1 | 14.3 | 64 | 46.0 |
| The forum or workshop where the findings were presented | 13 | 5.8 | 1 | 1.6 | 6 | 7.9 | 0 | 0 | 20 | 14.4 |
| Stakeholders groups attending the forum or workshop | 10 | 4.5 | 0 | 0 | 4 | 5.3 | 0 | 0 | 14 | 10.1 |
| People or agencies who requested copies of the findings | 3 | 1.3 | 2 | 3.2 | 3 | 3.9 | 0 | 0 | 8 | 5.8 |
| People or agencies who cited or reported the findings in a document | 2 | 0.9 | 1 | 1.6 | 2 | 2.6 | 0 | 0 | 5 | 3.6 |
| Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 |
| Total (all instances) | 224 | 100 | 63 | 100 | 76 | 100 | 7 | 100 | 370a | 100.0 |
| Additional details identified | ||||||||||
| On a website, or in an online media report, or in social media | 20 | 47.6 | 4 | 66.7 | 15 | 51.7 | 3 | 60 | 42 | 51.2 |
| In a white paper, other consultation or discussion document | 6 | 14.3 | 1 | 16.7 | 0 | 0 | 0 | 0 | 7 | 8.5 |
| In a new/revised policy or programme document | 4 | 9.5 | 1 | 16.7 | 2 | 6.9 | 0 | 0 | 7 | 8.5 |
| In a ministerial, policy brief or summary | 4 | 9.5 | 0 | 0 | 3 | 10.3 | 0 | 0 | 7 | 8.5 |
| In an email, e-bulletin or newsletter | 0 | 0 | 0 | 0 | 4 | 13.8 | 2 | 40 | 6 | 7.3 |
| In a clinical guideline, manual or other clinical resource | 4 | 9.5 | 0 | 0 | 1 | 3.4 | 0 | 0 | 5 | 6.1 |
| In the agenda or records of a meeting, forum or workshop | 3 | 7.1 | 0 | 0 | 1 | 3.4 | 0 | 0 | 4 | 4.9 |
| In an evaluation plan, protocol or document | 0 | 0 | 0 | 0 | 1 | 3.4 | 0 | 0 | 1 | 1.2 |
| In a grant application, research protocol or research report | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 |
| Other (media release) | 1 | 2.4 | 0 | 0 | 2 | 6.9 | 0 | 0 | 3 | 3.7 |
| Total (all instances) | 42 | 100 | 6 | 100 | 29 | 100 | 5 | 100 | 82b | 100.0 |
| Why were reviews not used? | ||||||||||
| The findings disagreed with an existing policy position | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| The findings told us nothing new about the issue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| The findings were not presented in a useful way | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| The findings gave us insufficient information to support action | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| There was a change in the policy environment | 2 | 2.4 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1.3 |
| There was no momentum for change in the agency or sector | 1 | 1.2 | 0 | 0 | 1 | 3.8 | 0 | 0 | 2 | 1.3 |
| It was difficult to integrate the findings in a policy or programme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Not stated | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.0 |
| Not applicable (reviews were used) | 81 | 96.4 | 25 | 100 | 25 | 96.2 | 4 | 100 | 134 | 90.0 |
| Not interviewed | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11 | 7.3 |
| Total (all instances) | 84 | 100 | 25 | 0 | 26 | 0 | 4 | 0 | 150 | 100 |
| What barriers were mentioned when reviews were used? | ||||||||||
| The findings disagreed with an existing policy position | 1 | 1.2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.7 |
| The findings told us nothing new about the issue | 0 | 0 | 0 | 0 | 1 | 3.8 | 0 | 0 | 1 | 0.7 |
| The findings were not presented in a useful way | 2 | 2.4 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1.3 |
| The findings gave us insufficient information to support action | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| There was a change in the policy environment | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 25 | 1 | 0.7 |
| There was no momentum for change in the agency or sector | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 |
| It was difficult to integrate the findings in a policy or programme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other (review was not completed in a timely way) | 1 | 1.2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.7 |
| Not stated (no barriers were mentioned) | 80 | 95.2 | 25 | 100 | 25 | 96.2 | 3 | 75 | 133 | 88 |
| Not interviewed | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11 | 7.3 |
| Total (all instances) | 84 | 100 | 25 | 0 | 26 | 100 | 4 | 100 | 150 | 100 |
aTotals > 150: details provided about use
bTotals < 150: 82 uses separately identified